These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 38869519)

  • 21. Palmitoylation on the carboxyl terminus tail is required for the selective regulation of dopamine D2 versus D3 receptors.
    Zhang X; Le HT; Zhang X; Zheng M; Choi BG; Kim KM
    Biochim Biophys Acta; 2016 Sep; 1858(9):2152-2162. PubMed ID: 27349735
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Differential induction of adenylyl cyclase supersensitivity by antiparkinson drugs acting as agonists at dopamine D1/D2/D3 receptors vs D2/D3 receptors only: parallel observations from co-transfected human and native cerebral receptors.
    Aloisi G; Silvano E; Rossi M; Millan MJ; Maggio R
    Neuropharmacology; 2011; 60(2-3):439-45. PubMed ID: 21035472
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dopamine D
    Wei H; Zapata RC; Lopez-Valencia M; Aslanoglou D; Farino ZJ; Benner V; Osborn O; Freyberg Z; McCarthy MJ
    Psychoneuroendocrinology; 2020 Mar; 113():104551. PubMed ID: 31884319
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Selective D
    Manvich DF; Petko AK; Branco RC; Foster SL; Porter-Stransky KA; Stout KA; Newman AH; Miller GW; Paladini CA; Weinshenker D
    Neuropsychopharmacology; 2019 Jul; 44(8):1445-1455. PubMed ID: 30879021
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The D2/D3 agonist PD128907 (R-(+)-trans-3,4a,10b-tetrahydro-4-propyl-2H,5H-[1]benzopyrano[4,3-b]-1,4-oxazin-9-ol) inhibits stimulated pyloric relaxation and spontaneous gastric emptying.
    Kashyap P; Micci MA; Pasricha S; Pasricha PJ
    Dig Dis Sci; 2009 Jan; 54(1):57-62. PubMed ID: 18600456
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Biased signaling agonist of dopamine D3 receptor induces receptor internalization independent of β-arrestin recruitment.
    Xu W; Reith MEA; Liu-Chen LY; Kortagere S
    Pharmacol Res; 2019 May; 143():48-57. PubMed ID: 30844536
    [TBL] [Abstract][Full Text] [Related]  

  • 27. D
    Shen Y; McCorvy JD; Martini ML; Rodriguiz RM; Pogorelov VM; Ward KM; Wetsel WC; Liu J; Roth BL; Jin J
    J Med Chem; 2019 May; 62(9):4755-4771. PubMed ID: 30964661
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhibition of 50-kHz ultrasonic vocalizations by dopamine receptor subtype-selective agonists and antagonists in adult rats.
    Scardochio T; Clarke PB
    Psychopharmacology (Berl); 2013 Apr; 226(3):589-600. PubMed ID: 23192317
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Distinct inactive conformations of the dopamine D2 and D3 receptors correspond to different extents of inverse agonism.
    Lane JR; Abramyan AM; Adhikari P; Keen AC; Lee KH; Sanchez J; Verma RK; Lim HD; Yano H; Javitch JA; Shi L
    Elife; 2020 Jan; 9():. PubMed ID: 31985399
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dopamine receptors modulate cytotoxicity of natural killer cells via cAMP-PKA-CREB signaling pathway.
    Zhao W; Huang Y; Liu Z; Cao BB; Peng YP; Qiu YH
    PLoS One; 2013; 8(6):e65860. PubMed ID: 23799052
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Implication of dopamine D3 receptor activation in the reversion of Parkinson's disease-related motivational deficits.
    Carnicella S; Drui G; Boulet S; Carcenac C; Favier M; Duran T; Savasta M
    Transl Psychiatry; 2014 Jun; 4(6):e401. PubMed ID: 24937095
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Expression of dopamine D2 and D3 receptors in the human retina revealed by positron emission tomography and targeted mass spectrometry.
    Caravaggio F; Scifo E; Sibille EL; Hernandez-Da Mota SE; Gerretsen P; Remington G; Graff-Guerrero A
    Exp Eye Res; 2018 Oct; 175():32-41. PubMed ID: 29883636
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Activation of dopamine D
    Liu XY; Zheng LF; Fan YY; Shen QY; Qi Y; Li GW; Sun Q; Zhang Y; Feng XY; Zhu JX
    Am J Physiol Cell Physiol; 2022 Mar; 322(3):C327-C337. PubMed ID: 34986020
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The dopamine receptor D2 agonist bromocriptine inhibits glucose-stimulated insulin secretion by direct activation of the alpha2-adrenergic receptors in beta cells.
    de Leeuw van Weenen JE; Parlevliet ET; Maechler P; Havekes LM; Romijn JA; Ouwens DM; Pijl H; Guigas B
    Biochem Pharmacol; 2010 Jun; 79(12):1827-36. PubMed ID: 20138024
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evidence-based practice use of quick-release bromocriptine across the natural history of type 2 diabetes mellitus.
    Schwartz SS; Zangeneh F
    Postgrad Med; 2016 Nov; 128(8):828-838. PubMed ID: 27458683
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Activity, non-selective attention and emotionality in dopamine D2/D3 receptor knock-out mice.
    Vallone D; Pignatelli M; Grammatikopoulos G; Ruocco L; Bozzi Y; Westphal H; Borrelli E; Sadile AG
    Behav Brain Res; 2002 Mar; 130(1-2):141-8. PubMed ID: 11864730
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Overexpression of D2/D3 receptors increases efficacy of ropinirole in chronically 6-OHDA-lesioned Parkinsonian rats.
    Matsukawa N; Maki M; Yasuhara T; Hara K; Yu G; Xu L; Kim KM; Morgan JC; Sethi KD; Borlongan CV
    Brain Res; 2007 Jul; 1160():113-23. PubMed ID: 17573046
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evidence for Noncanonical Neurotransmitter Activation: Norepinephrine as a Dopamine D2-Like Receptor Agonist.
    Sánchez-Soto M; Bonifazi A; Cai NS; Ellenberger MP; Newman AH; Ferré S; Yano H
    Mol Pharmacol; 2016 Apr; 89(4):457-66. PubMed ID: 26843180
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Regional and source-based patterns of [
    Worhunsky PD; Matuskey D; Gallezot JD; Gaiser EC; Nabulsi N; Angarita GA; Calhoun VD; Malison RT; Potenza MN; Carson RE
    Neuroimage; 2017 Mar; 148():343-351. PubMed ID: 28110088
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tolerance to peripheral, but not central, effects of ropinirole, a selective dopamine D2-like receptor agonist.
    Parker SG; Raval P; Yeulet S; Eden RJ
    Eur J Pharmacol; 1994 Nov; 265(1-2):17-26. PubMed ID: 7883025
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.